Source: European Medicines Agency (EU) Publisher: Glenmark Pharmaceuticals s.r.o., Hvězdova 1716/2b, 140 78, Praha 4, Czech Republic
Triflusal.
| Pharmaceutical Form |
|---|
|
Hard capsule. Clear hard gelatin capsules containing a white powder. |
Each capsule contains 300 mg of triflusal.
| Active Ingredient | Description | |
|---|---|---|
| Triflusal |
Triflusal reduces thromboxan biosynthesis through irreversible inhibition of platelet cyclooxygenase, sparing prostacyclin biosynthesis because its effect on vascular cyclooxygenase at therapeutic doses is negligible. |
| List of Excipients |
|---|
|
Contains no excipients, except for the gelatin in the capsule. |
Aluminium/PVC-PVDC blisters.
Carton box with 3 PVC/PVDC with 10 hard capsules.
Carton box with 5 PVC/PVDC with 10 hard capsules.
Carton box with 6 PVC/PVDC with 10 hard capsules.
Carton box with 9 PVC/PVDC with 10 hard capsules.
Glenmark Pharmaceuticals s.r.o., Hvězdova 1716/2b, 140 78, Praha 4, Czech Republic
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
